What nurses need to know about weight-loss drugs
Pavan Amara Nurse, midwife and health journalist
An update on weight-loss drugs semaglutide (Wegovy) and tirzepatide (Mounjaro), and the alternatives available
Weight-loss injections, such as Wegovy and Mounjaro, are gaining more attention as pharmacological ways to combat obesity. The UK government has even suggested they could help get some unemployed people back into work. Here’s what nurses need to know.
Mental Health Practice.
28, 1, 10-11.
doi: 10.7748/mhp.28.1.10.s4
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Are you a student? Our student subscription has content especially for you.
Find out more
